Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE
- PMID: 22315040
- DOI: 10.1039/c2mb05390j
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE
Abstract
Renal cell carcinoma (RCC), the most common neoplasm affecting the adult kidney, is characterised by heterogeneity of histological subtypes, drug resistance, and absence of molecular markers. Two-dimensional difference gel electrophoresis (2-D DIGE) technology in combination with mass spectrometry (MS) was applied to detect differentially expressed proteins in 20 pairs of RCC tissues and matched adjacent normal kidney cortex (ANK), in order to search for RCC markers. After gel analysis by DeCyder 6.5 and EDA software, differentially expressed protein spots were excised from Deep Purple stained preparative 2DE gel. A total of 100 proteins were identified by MS out of 2500 spots, 23 and 77 of these were, respectively, over- and down-expressed in RCC. The Principal Component Analysis applied to gels and protein spots exactly separated the two sample classes in two groups: RCC and ANK. Moreover, some spots, including ANXA2, PPIA, FABP7 and LEG1, resulted highly differential. The DIGE data were also confirmed by immunoblotting analysis for these proteins. In conclusion, we suggest that applying 2-D DIGE to RCC may provide the basis for a better molecular characterization and for the discovery of candidate biomarkers.
Similar articles
-
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.Mol Biosyst. 2012 Apr;8(4):985-93. doi: 10.1039/c1mb05386h. Epub 2011 Dec 2. Mol Biosyst. 2012. PMID: 22134777
-
Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.Saudi Med J. 2010 May;31(5):525-32. Saudi Med J. 2010. PMID: 20464042
-
Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.J Proteome Res. 2005 Nov-Dec;4(6):2062-9. doi: 10.1021/pr0502018. J Proteome Res. 2005. PMID: 16335951
-
State of the art of 2D DIGE.Proteomics Clin Appl. 2015 Apr;9(3-4):277-88. doi: 10.1002/prca.201400119. Epub 2015 Feb 19. Proteomics Clin Appl. 2015. PMID: 25400138 Review.
-
Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):2-8. doi: 10.1016/j.bbapap.2018.07.002. Epub 2018 Jul 7. Biochim Biophys Acta Proteins Proteom. 2019. PMID: 30392560 Review.
Cited by
-
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma.Front Med (Lausanne). 2022 Jun 14;9:766869. doi: 10.3389/fmed.2022.766869. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35775004 Free PMC article. Review.
-
Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.PLoS One. 2014 Nov 4;9(11):e111364. doi: 10.1371/journal.pone.0111364. eCollection 2014. PLoS One. 2014. PMID: 25368985 Free PMC article.
-
The proteomics big challenge for biomarkers and new drug-targets discovery.Int J Mol Sci. 2012 Oct 29;13(11):13926-48. doi: 10.3390/ijms131113926. Int J Mol Sci. 2012. PMID: 23203042 Free PMC article. Review.
-
Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.Tumour Biol. 2015 Jul;36(7):5109-18. doi: 10.1007/s13277-015-3163-2. Epub 2015 Feb 14. Tumour Biol. 2015. PMID: 25677901
-
Proteomics Characterization of Clear Cell Renal Cell Carcinoma.J Clin Med. 2023 Jan 3;12(1):384. doi: 10.3390/jcm12010384. J Clin Med. 2023. PMID: 36615183 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous